Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
Sales | 689,230 | 556,140 | 338,260 | 194,120 | 152,935 |
Cost of Goods | 230,630 | 208,650 | 125,050 | 77,030 | 64,996 |
Gross Profit | 458,590 | 347,490 | 213,200 | 117,080 | 87,939 |
Operating Expenses | 201,320 | 142,360 | 76,240 | 34,400 | 36,599 |
Operating Income | 257,910 | 205,780 | 137,020 | 82,720 | 52,336 |
Interest Expense | 11,120 | 7,060 | 0 | 0 | 0 |
Other Income | 25,750 | 350 | 7,570 | 26,450 | 20,421 |
Pre-tax Income | 272,540 | 199,070 | 144,590 | 109,170 | 72,757 |
Income Tax | 93,660 | 78,240 | 54,410 | 35,870 | 24,867 |
Net Income Continuous | 163,368 | 133,829 | 105,133 | 73,298 | 52,968 |
Net Income | $178,880 | $120,820 | $90,180 | $73,290 | $47,890 |
EPS Basic Total Ops | 1.83 | 1.32 | 1.04 | 0.98 | 0.65 |
EPS Basic Continuous Ops | 1.67 | 1.46 | 1.21 | 0.97 | 0.71 |
EPS Diluted Total Ops | 1.83 | 1.32 | 1.01 | 0.98 | 0.65 |
EPS Diluted Continuous Ops | 1.67 | 1.46 | 1.18 | 0.97 | 0.71 |
EBITDA(a) | $301,910 | $237,090 | $151,610 | $89,830 | $57,579 |